Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VOR is expected to report earnings to fall 3.03% to -87 cents per share on March 25
Q4'26
Est.
$-0.87
Q3'26
Missed
by $0.09
Q2'26
Missed
by $0.43
Q1'26
Missed
by $5.01
Q4'25
Beat
by $84.98
The last earnings report on October 30 showed earnings per share of -89 cents, missing the estimate of -81 cents. With 4.51K shares outstanding, the current market capitalization sits at 1.14B.